Drug eluting stents in adults with in-stent restenosis: a review of the clinical effectiveness, safety and guidelines
CADTH
Record ID 32012000706
English
Authors' recommendations:
Patients with in-stent restenosis, when treated with drug eluting stents, had less target vessel revascularization and target lesion revascularization in comparison to vascular brachytherapy or balloon angioplasty; incidences of death and stent thrombosis were similar. However, robust long term data is lacking. One guideline recommends the use of DES for in-stent restenosis patients under specific circumstances.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
http://www.cadth.ca/media/pdf/htis/aug-2012/RC0382-DES-Restenosis%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Coronary Restenosis
- Safety
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.